Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Pharmacology|January 1, 1986
Renal noradrenergic and dopaminergic activity in patients with borderline essential hypertensionM Castellano, M Beschi, E Agabiti-Rossi, et al.
American Journal of Hypertension|April 1, 1991
Renal and hemodynamic effects of atrial natriuretic peptide infusion are not mediated by peripheral dopaminergic mechanismsM Castellano, M Beschi, E Agabiti-Rosei, et al.
Giornale Italiano Di Cardiologia|January 1, 1980
[A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)]G Muiesan, E Agabiti-Rosei, R Buoninconti, et al.
The Journal of International Medical Research|January 1, 1984
Efficacy of low-dose captopril given twice daily to patients with essential hypertension uncontrolled by a beta blocker plus thiazide diureticG Muiesan, C Alicandri, E Agabiti-Rosei, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Adrenergic activity in systolic hypertensionE Agabiti-Rosei, C Alicandri, R Fariello, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimenG Muiesan, E Agabiti-Rosei, A Carotti, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1987
Antihypertensive efficacy and tolerability of captopril in the elderly: comparison with hydrochlorothiazide and placebo in a multicentre, double-blind studyG Muiesan, E Agabiti-Rosei, R Buoninconti, et al.
British Journal of Clinical Pharmacology|June 1, 1982
The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levelsE Agabiti-Rosei, C L Alicandri, M Beschi, et al.
Pageof 9